The VYBE247™ MIT MINIS line was created with one simple goal: to provide customers with a straightforward, consistent, and thoughtfully designed full-spectrum mitragynine product. Rather than relying on oversized quad-scored tablets that can be difficult to divide into even portions, MIT MINIS feature individually portioned mini tablets that make product selection simple and consistent.

As the market continues to evolve, many customers have expressed interest in products that focus on the kratom plant itself rather than synthetic alkaloids. The MIT MINIS collection reflects that preference by featuring 0% 7OH and 0% synthetic alkaloids, while utilizing full-spectrum mitragynine extract. Available in strengths ranging from 2500MG down to 250MG, the lineup gives customers the flexibility to choose the concentration that best aligns with their individual preferences, all within one consistent product family.

At VYBE247, we believe quality starts with transparency, consistency, and attention to detail. Every MIT MINI is developed with those principles in mind, delivering a convenient format designed for customers who value precision, simplicity, and choice.

Notice: VYBE247™ MIT MINIS are research compounds intended for laboratory research and analytical purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure, or prevent any disease. They are not for human consumption.